These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 9321394)

  • 41. Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells.
    Skorski T; Kanakaraj P; Nieborowska-Skorska M; Ratajczak MZ; Wen SC; Zon G; Gewirtz AM; Perussia B; Calabretta B
    Blood; 1995 Jul; 86(2):726-36. PubMed ID: 7606002
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Black raspberry extracts inhibit benzo(a)pyrene diol-epoxide-induced activator protein 1 activation and VEGF transcription by targeting the phosphotidylinositol 3-kinase/Akt pathway.
    Huang C; Li J; Song L; Zhang D; Tong Q; Ding M; Bowman L; Aziz R; Stoner GD
    Cancer Res; 2006 Jan; 66(1):581-7. PubMed ID: 16397275
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The coiled-coil domain and Tyr177 of bcr are required to induce a murine chronic myelogenous leukemia-like disease by bcr/abl.
    He Y; Wertheim JA; Xu L; Miller JP; Karnell FG; Choi JK; Ren R; Pear WS
    Blood; 2002 Apr; 99(8):2957-68. PubMed ID: 11929787
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Resistance against Friend leukemia virus-induced leukemogenesis in DNA-dependent protein kinase (DNA-PK)-deficient scid mice associated with defective viral integration at the Spi-1 and Fli-1 site.
    Hasegawa M; Yamaguchi S; Aizawa S; Ikeda H; Tatsumi K; Noda Y; Hirokawa K; Kitagawa M
    Leuk Res; 2005 Aug; 29(8):933-42. PubMed ID: 15978944
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PI-3K/Akt pathway-dependent cyclin D1 expression is responsible for arsenite-induced human keratinocyte transformation.
    Ouyang W; Luo W; Zhang D; Jian J; Ma Q; Li J; Shi X; Chen J; Gao J; Huang C
    Environ Health Perspect; 2008 Jan; 116(1):1-6. PubMed ID: 18197291
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pim-1 expression is sufficient to induce cytokine independence in murine hematopoietic cells, but is dispensable for BCR-ABL-mediated transformation.
    Nosaka T; Kitamura T
    Exp Hematol; 2002 Jul; 30(7):697-702. PubMed ID: 12135666
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Involvement of Jak2 tyrosine phosphorylation in Bcr-Abl transformation.
    Xie S; Wang Y; Liu J; Sun T; Wilson MB; Smithgall TE; Arlinghaus RB
    Oncogene; 2001 Sep; 20(43):6188-95. PubMed ID: 11593427
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bcr-Abl with an SH3 deletion retains the ability To induce a myeloproliferative disease in mice, yet c-Abl activated by an SH3 deletion induces only lymphoid malignancy.
    Gross AW; Zhang X; Ren R
    Mol Cell Biol; 1999 Oct; 19(10):6918-28. PubMed ID: 10490629
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gi-mediated translocation of GLUT4 is independent of p85/p110alpha and p110gamma phosphoinositide 3-kinases but might involve the activation of Akt kinase.
    Wang L; Hayashi H; Kishi K; Huang L; Hagi A; Tamaoka K; Hawkins PT; Ebina Y
    Biochem J; 2000 Feb; 345 Pt 3(Pt 3):543-55. PubMed ID: 10642513
    [TBL] [Abstract][Full Text] [Related]  

  • 50. C-RAF-1 serine/threonine kinase is required in BCR/ABL-dependent and normal hematopoiesis.
    Skorski T; Nieborowska-Skorska M; Szczylik C; Kanakaraj P; Perrotti D; Zon G; Gewirtz A; Perussia B; Calabretta B
    Cancer Res; 1995 Jun; 55(11):2275-8. PubMed ID: 7757976
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cooperation between STAT5 and phosphatidylinositol 3-kinase in the IL-3-dependent survival of a bone marrow derived cell line.
    Rosa Santos SC; Dumon S; Mayeux P; Gisselbrecht S; Gouilleux F
    Oncogene; 2000 Feb; 19(9):1164-72. PubMed ID: 10713704
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Growth of chronic myeloid leukemia cells is inhibited by infection with Ad-SH2-HA adenovirus that disrupts Grb2-Bcr-Abl complexes.
    Peng Z; Luo HW; Yuan Y; Shi J; Huang SF; Li CL; Cao WX; Huang ZG; Feng WL
    Oncol Rep; 2011 May; 25(5):1381-8. PubMed ID: 21369701
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Blastic transformation of p53-deficient bone marrow cells by p210bcr/abl tyrosine kinase.
    Skorski T; Nieborowska-Skorska M; Wlodarski P; Perrotti D; Martinez R; Wasik MA; Calabretta B
    Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13137-42. PubMed ID: 8917557
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adhesion to fibronectin selectively protects Bcr-Abl+ cells from DNA damage-induced apoptosis.
    van der Kuip H; Goetz AW; Miething C; Duyster J; Aulitzky WE
    Blood; 2001 Sep; 98(5):1532-41. PubMed ID: 11520804
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential expression and signaling of CBL and CBL-B in BCR/ABL transformed cells.
    Sattler M; Pride YB; Quinnan LR; Verma S; Malouf NA; Husson H; Salgia R; Lipkowitz S; Griffin JD
    Oncogene; 2002 Feb; 21(9):1423-33. PubMed ID: 11857085
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transformation of interleukin-3-dependent cells without participation of Stat5/bcl-xL: cooperation of akt with raf/erk leads to p65 nuclear factor kappaB-mediated antiapoptosis involving c-IAP2.
    Gelfanov VM; Burgess GS; Litz-Jackson S; King AJ; Marshall MS; Nakshatri H; Boswell HS
    Blood; 2001 Oct; 98(8):2508-17. PubMed ID: 11588049
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role for the adaptor protein Grb10 in the activation of Akt.
    Jahn T; Seipel P; Urschel S; Peschel C; Duyster J
    Mol Cell Biol; 2002 Feb; 22(4):979-91. PubMed ID: 11809791
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Targeting the phosphatidylinositol 3-kinase/Akt pathway for enhancing breast cancer cells to radiotherapy.
    Liang K; Jin W; Knuefermann C; Schmidt M; Mills GB; Ang KK; Milas L; Fan Z
    Mol Cancer Ther; 2003 Apr; 2(4):353-60. PubMed ID: 12700279
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Initiation factor eIF2B not p70 S6 kinase is involved in the activation of the PI-3K signalling pathway induced by the v-src oncogene.
    Vojtechová M; Sloncová E; Kucerová D; Jiricka J; Sovová V; Tuhácková Z
    FEBS Lett; 2003 May; 543(1-3):81-6. PubMed ID: 12753910
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis.
    Cortez D; Kadlec L; Pendergast AM
    Mol Cell Biol; 1995 Oct; 15(10):5531-41. PubMed ID: 7565705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.